无数据
扫 描 看 全 文
Clinical Lab, Taicang Hospital of Traditional Chinese Medicine, Suzhou 215400, China
Key Laboratory of Medical Science and Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang 212013, China
1.Key Laboratory of Medical Science and Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang 212013, China
2.Nanjing Lishui People’s Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing 211200, China
3.Directorate of University Health Services, University of Cape Coast, Cape Coast, Ghana
4.Department of Gastroenterology, the Second People’s Hospital of Zhenjiang, Zhenjiang 212000, China
5.Clinical Lab, Taicang Hospital of Traditional Chinese Medicine, Suzhou 215400, China
纸质出版日期: 2022-05-15 ,
收稿日期: 2021-09-15 ,
修回日期: 2022-01-27 ,
引用本文
HucMSC-Ex通过调控lnc78583介导的miR3202/HOXB13通路缓解炎症性肠病[J]. 浙江大学学报(英文版)(B辑:生物医学和生物技术), 2022, 23(5):423-431.
Yuting XU, Li ZHANG, Dickson Kofi Wiredu OCANSEY, et al. HucMSC-Ex alleviates inflammatory bowel disease via the lnc78583-mediated miR3202/HOXB13 pathway[J]. Journal of Zhejiang University-SCIENCE B(Biomedicine & Biotechnology), 2022, 23(5):423-431.
HucMSC-Ex通过调控lnc78583介导的miR3202/HOXB13通路缓解炎症性肠病[J]. 浙江大学学报(英文版)(B辑:生物医学和生物技术), 2022, 23(5):423-431. DOI: 10.1631/jzus.B2100793.
Yuting XU, Li ZHANG, Dickson Kofi Wiredu OCANSEY, et al. HucMSC-Ex alleviates inflammatory bowel disease via the lnc78583-mediated miR3202/HOXB13 pathway[J]. Journal of Zhejiang University-SCIENCE B(Biomedicine & Biotechnology), 2022, 23(5):423-431. DOI: 10.1631/jzus.B2100793.
0
浏览量
1
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构